Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 5111-5117, September 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Markovits, J.
Right arrow Articles by Larsen, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Markovits, J.
Right arrow Articles by Larsen, A. K.

Inhibitory Effects of the Tyrosine Kinase Inhibitor Genistein on Mammalian DNA Topoisomerase II1

Judith Markovits2, Claude Linassier, Philippe Fossé, Jeanine Couprie, Josiane Pierre, Alain Jacquemin-Sablon, Jean-Marie Saucier, Jean-Bernard Le Pecq and Annette K. Larsen

Laboratoire de Pharmacologie Moléculaire, URA 158 du CNRS, U 140 de l'INSERM, Institut Gustave Roussy, 94805 Villejuif Cédex, France

Tyrosine phosphorylation plays a crucial role in cell proliferation and cell transformation which suggests that tyrosine kinase-specific inhibitors might be used as anticancer agents. When the cytotoxic effect of the potent tyrosine kinase inhibitor genistein on various cell lines was studied, we observed that 9-hydroxyellipticine-resistant Chinese hamster lung cells (DC-3F/9-OH-E) were markedly more resistant to genistein than the parental cell line (DC-3F). The DC-3F/9-OH-E cells have been shown to have an altered DNA topoisomerase II activity. We therefore examined the effects of genistein on DNA topoisomerase II-related activities of nuclear extracts from DC-3F cells as well as on purified DNA topoisomerase II from calf thymus. Our results show that genistein (a) inhibits the decatenation activity of DNA topoisomerase II and (b) stimulates DNA topoisomerase II-mediated double strand breaks in pBR322 DNA on sites different from those of 4'-(9-acridinylamino)methanesulfon-m-anisidide, etoposide, and 2-methyl-9-hydroxyellipticinium. Structure-activity studies with six chemically related compounds show that only genistein has an effect on the cleavage activity of DNA topoisomerase II in the concentration range studied. Finally, genistein treatment of DC-3F cells results in the occurrence of protein-linked DNA strand breaks as shown by DNA filter elution. Viscometric (lengthening) studies demonstrate that genistein is not a DNA intercalator. Genistein is therefore an interesting compound because it induces cleavable complexes without intercalation.

Taken together, our results show that genistein is an inhibitor of both protein tyrosine kinases and mammalian DNA topoisomerase II. This could be accounted for by the sharing of a common structure sequence between the two proteins at the ATP binding site.

1 Supported by grants from Université Pierre et Marie Curie (Paris VI), CNRS, INSERM; Ligue Nationale Française contre le Cancer; Association pour la Recherche contre le Cancer; and Fondation pour la Recherche Médicale. Part of this work has been presented at the second conference on DNA Topoisomerases in Cancer Chemotherapy, New York, October 1988.

2 To whom requests for reprints should be addressed.

Received 2/ 2/89. Revised 6/ 7/89. Accepted 6/19/89.




This article has been cited by other articles:


Home page
Hum ReprodHome page
A.B. Moore, L. Castro, L. Yu, X. Zheng, X. Di, M.I. Sifre, G.E. Kissling, R.R. Newbold, C.D. Bortner, and D. Dixon
Stimulatory and inhibitory effects of genistein on human uterine leiomyoma cell proliferation are influenced by the concentration
Hum. Reprod., October 1, 2007; 22(10): 2623 - 2631.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Atteritano, H. Marini, L. Minutoli, F. Polito, A. Bitto, D. Altavilla, S. Mazzaferro, R. D'Anna, M. L. Cannata, A. Gaudio, et al.
Effects of the Phytoestrogen Genistein on Some Predictors of Cardiovascular Risk in Osteopenic, Postmenopausal Women: A Two-Year Randomized, Double-Blind, Placebo-Controlled Study
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3068 - 3075.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Dijsselbloem, S. Goriely, V. Albarani, S. Gerlo, S. Francoz, J.-C. Marine, M. Goldman, G. Haegeman, and W. V. Berghe
A Critical Role for p53 in the Control of NF-{kappa}B-Dependent Gene Expression in TLR4-Stimulated Dendritic Cells Exposed to Genistein
J. Immunol., April 15, 2007; 178(8): 5048 - 5057.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H.-K. Kim, C. Nelson-Dooley, M. A. Della-Fera, J.-Y. Yang, W. Zhang, J. Duan, D. L. Hartzell, M. W. Hamrick, and C. A. Baile
Genistein Decreases Food Intake, Body Weight, and Fat Pad Weight and Causes Adipose Tissue Apoptosis in Ovariectomized Female Mice
J. Nutr., February 1, 2006; 136(2): 409 - 414.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M Maggiolini, A G Recchia, D Bonofiglio, S Catalano, A Vivacqua, A Carpino, V Rago, R Rossi, and S Ando
The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor {alpha} in human breast cancer cells
J. Mol. Endocrinol., October 1, 2005; 35(2): 269 - 281.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Z. Fang, D. Chen, Y. Sun, Z. Jin, J. K. Christman, and C. S. Yang
Reversal of Hypermethylation and Reactivation of p16INK4a, RAR{beta}, and MGMT Genes by Genistein and Other Isoflavones from Soy
Clin. Cancer Res., October 1, 2005; 11(19): 7033 - 7041.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
V. Selvaraj, D. Bunick, C. Finnigan-Bunick, R. W. Johnson, H. Wang, L. Liu, and P. S. Cooke
Gene Expression Profiling of 17{beta}-Estradiol and Genistein Effects on Mouse Thymus
Toxicol. Sci., September 1, 2005; 87(1): 97 - 112.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
B. E. Deavours and R. A. Dixon
Metabolic Engineering of Isoflavonoid Biosynthesis in Alfalfa
Plant Physiology, August 1, 2005; 138(4): 2245 - 2259.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Huang, S. Cao, M. Nagamani, K. E. Anderson, J. J. Grady, and L.-J. W. Lu
Decreased Circulating Levels of Tumor Necrosis Factor-{alpha} in Postmenopausal Women during Consumption of Soy-Containing Isoflavones
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3956 - 3962.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. J. Baker and K. L. Hamilton
Genistein stimulates electrogenic Cl- secretion in mouse jejunum
Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1636 - C1645.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
V. Selvaraj, M. A. Zakroczymski, A. Naaz, M. Mukai, Y. H. Ju, D. R. Doerge, J. A. Katzenellenbogen, W. G. Helferich, and P. S. Cooke
Estrogenicity of the Isoflavone Metabolite Equol on Reproductive and Non-Reproductive Organs in Mice
Biol Reprod, September 1, 2004; 71(3): 966 - 972.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. E. Wood, T. C. Register, M. S. Anthony, N. D. Kock, and J. M. Cline
Breast and Uterine Effects of Soy Isoflavones and Conjugated Equine Estrogens in Postmenopausal Female Monkeys
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3462 - 3468.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A.-C. Chen and S. M. Donovan
Genistein at a Concentration Present in Soy Infant Formula Inhibits Caco-2BBe Cell Proliferation by Causing G2/M Cell Cycle Arrest
J. Nutr., June 1, 2004; 134(6): 1303 - 1308.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. B. Grace, J. I. Taylor, Y.-L. Low, R. N. Luben, A. A. Mulligan, N. P. Botting, M. Dowsett, A. A. Welch, K.-T. Khaw, N. J. Wareham, et al.
Phytoestrogen Concentrations in Serum and Spot Urine as Biomarkers for Dietary Phytoestrogen Intake and Their Relation to Breast Cancer Risk in European Prospective Investigation of Cancer and Nutrition-Norfolk
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 698 - 708.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
S.-Y. Kim, S.-J. Kim, J.-Y. Lee, W.-G. Kim, W.-S. Park, Y.-C. Sim, and S.-J. Lee
Protective Effects of Dietary Soy Isoflavones against UV-Induced Skin-Aging in Hairless Mouse Model
J. Am. Coll. Nutr., April 1, 2004; 23(2): 157 - 162.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
D. G. Gilliland, C. T. Jordan, and C. A. Felix
The Molecular Basis of Leukemia
Hematology, January 1, 2004; 2004(1): 80 - 97.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Wei, R. Saladi, Y. Lu, Y. Wang, S. R. Palep, J. Moore, R. Phelps, E. Shyong, and M. G. Lebwohl
Isoflavone Genistein: Photoprotection and Clinical Implications in Dermatology
J. Nutr., November 1, 2003; 133(11): 3811S - 3819.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
A. Lynch, J. Harvey, M. Aylott, E. Nicholas, M. Burman, A. Siddiqui, S. Walker, and R. Rees
Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity
Mutagenesis, July 1, 2003; 18(4): 345 - 353.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
C. E. Piersen
Phytoestrogens in Botanical Dietary Supplements: Implications for Cancer
Integr Cancer Ther, June 1, 2003; 2(2): 120 - 138.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
Z.-C. Dang, V. Audinot, S. E. Papapoulos, J. A. Boutin, and C. W. G. M. Lowik
Peroxisome Proliferator-activated Receptor gamma (PPARgamma ) as a Molecular Target for the Soy Phytoestrogen Genistein
J. Biol. Chem., January 3, 2003; 278(2): 962 - 967.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
W. A. Weiger, M. Smith, H. Boon, M. A. Richardson, T. J. Kaptchuk, and D. M. Eisenberg
Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer
Ann Intern Med, December 3, 2002; 137(11): 889 - 903.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. J Bhathena and M. T Velasquez
Beneficial role of dietary phytoestrogens in obesity and diabetes
Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1191 - 1201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. T Bloedon, A R. Jeffcoat, W. Lopaczynski, M. J Schell, T. M Black, K. J Dix, B. F Thomas, C. Albright, M. G Busby, J. A Crowell, et al.
Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women
Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1126 - 1137.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Maggiolini, A. Vivacqua, A. Carpino, D. Bonofiglio, G. Fasanella, M. Salerno, D. Picard, and S. Ando
The Mutant Androgen Receptor T877A Mediates the Proliferative but Not the Cytotoxic Dose-Dependent Effects of Genistein and Quercetin on Human LNCaP Prostate Cancer Cells
Mol. Pharmacol., November 1, 2002; 62(5): 1027 - 1035.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. Kallay, H. Adlercreutz, H. Farhan, D. Lechner, E. Bajna, W. Gerdenitsch, M. Campbell, and H. S. Cross
Phytoestrogens Regulate Vitamin D Metabolism in the Mouse Colon: Relevance for Colon Tumor Prevention and Therapy
J. Nutr., November 1, 2002; 132(11): 3490S - 3493.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Dawn, H. Takano, X.-L. Tang, E. Kodani, S. Banerjee, A. Rezazadeh, Y. Qiu, and R. Bolli
Role of Src protein tyrosine kinases in late preconditioning against myocardial infarction
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H549 - H556.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
R. W. BRUEGGEMEIER, X. GU, J. A. MOBLEY, S. JOOMPRABUTRA, A. S. BHAT, and J. L. WHETSTONE
Effects of Phytoestrogens and Synthetic Combinatorial Libraries on Aromatase, Estrogen Biosynthesis, and Metabolism
Ann. N.Y. Acad. Sci., December 1, 2001; 948(1): 51 - 66.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. J. Linford, Y. Yang, D. G. Cook, and D. M. Dorsa
Neuronal Apoptosis Resulting from High Doses of the Isoflavone Genistein: Role for Calcium and P42/44 Mitogen-Activated Protein Kinase
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 67 - 75.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. D. Allred, Y. H. Ju, K. F. Allred, J. Chang, and W. G. Helferich
Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein
Carcinogenesis, October 1, 2001; 22(10): 1667 - 1673.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Mentor-Marcel, C. A. Lamartiniere, I.-E. Eltoum, N. M. Greenberg, and A. Elgavish
Genistein in the Diet Reduces the Incidence of Poorly Differentiated Prostatic Adenocarcinoma in Transgenic Mice (TRAMP)
Cancer Res., September 1, 2001; 61(18): 6777 - 6782.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Maggiolini, D. Bonofiglio, S. Marsico, M. L. Panno, B. Cenni, D. Picard, and S. Ando
Estrogen Receptor alpha Mediates the Proliferative but Not the Cytotoxic Dose-Dependent Effects of Two Major Phytoestrogens on Human Breast Cancer Cells
Mol. Pharmacol., September 1, 2001; 60(3): 595 - 602.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Yamagishi, E. Otsuka, and H. Hagiwara
Reciprocal Control of Expression of mRNAs for Osteoclast Differentiation Factor and OPG in Osteogenic Stromal Cells by Genistein: Evidence for the Involvement of Topoisomerase II in Osteoclastogenesis
Endocrinology, August 1, 2001; 142(8): 3632 - 3637.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
E. Middleton Jr., C. Kandaswami, and T. C. Theoharides
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
Pharmacol. Rev., December 1, 2000; 52(4): 673 - 751.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. H. Wu, D. Yang, and M. C. Pike
A Meta-Analysis of Soyfoods and Risk of Stomach Cancer: The Problem of Potential Confounders
Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1051 - 1058.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. A. Goddard, M. J. Evans, and W. H. Colledge
Genistein activates CFTR-mediated Cl- secretion in the murine trachea and colon
Am J Physiol Cell Physiol, August 1, 2000; 279(2): C383 - C392.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. C. Santell, N. Kieu, and W. G. Helferich
Genistein Inhibits Growth of Estrogen-Independent Human Breast Cancer Cells in Culture but Not in Athymic Mice
J. Nutr., July 1, 2000; 130(7): 1665 - 1669.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J.-M. Darbon, M. Penary, N. Escalas, F. Casagrande, F. Goubin-Gramatica, C. Baudouin, and B. Ducommun
Distinct Chk2 Activation Pathways Are Triggered by Genistein and DNA-damaging Agents in Human Melanoma Cells
J. Biol. Chem., May 12, 2000; 275(20): 15363 - 15369.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Ohta, S. Nakatsugi, K. Watanabe, T. Kawamori, F. Ishikawa, M. Morotomi, S. Sugie, T. Toda, T. Sugimura, and K. Wakabayashi
Inhibitory effects of Bifidobacterium-fermented soy milk on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones
Carcinogenesis, May 1, 2000; 21(5): 937 - 941.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Ikeda, A. Nishikawa, T. Imazawa, S. Kimura, and M. Hirose
Dramatic synergism between excess soybean intake and iodine deficiency on the development of rat thyroid hyperplasia
Carcinogenesis, April 1, 2000; 21(4): 707 - 713.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
L. R. White, H. Petrovitch, G. W. Ross, K. Masaki, J. Hardman, J. Nelson, D. Davis, and W. Markesbery
Brain Aging and Midlife Tofu Consumption
J. Am. Coll. Nutr., April 1, 2000; 19(2): 242 - 255.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Z. Yan, D. C. H. Yang, R. Neill, and M. Jett
Production of Tumor Necrosis Factor Alpha in Human T Lymphocytes by Staphylococcal Enterotoxin B Correlates with Toxin-Induced Proliferation and Is Regulated through Protein Kinase C
Infect. Immun., December 1, 1999; 67(12): 6611 - 6618.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Khelifa, B. Rene, S. L. Mee, B. Lambert, J.-M. Saucier, J. Markovits, H. Jacquemin-Sablon, and A. Jacquemin-Sablon
Transfection of 9-Hydroxyellipticine-resistant Chinese Hamster Fibroblasts with Human Topoisomerase II{{alpha}} cDNA: Selective Restoration of the Sensitivity to DNA Religation Inhibitors
Cancer Res., October 1, 1999; 59(19): 4927 - 4936.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. D. SCHULTZ, A. K. SINGH, D. C. DEVOR, and R. J. BRIDGES
Pharmacology of CFTR Chloride Channel Activity
Physiol Rev, January 1, 1999; 79(1): 109 - 144.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Wu, H. Huang, Z. Miner, and M. Kulesz-Martin
Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53
PNAS, August 19, 1997; 94(17): 8982 - 8987.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Lassota, G. Singh, and R. Kramer
Mechanism of Topoisomerase II Inhibition by Staurosporine and Other Protein Kinase Inhibitors
J. Biol. Chem., October 18, 1996; 271(42): 26418 - 26423.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Vera, A. M. Reyes, J. G. Cárcamo, F. V. Velásquez, C. I. Rivas, R. H. Zhang, P. Strobel, R. Iribarren, H. I. Scher, J. C. Slebe, et al.
Genistein Is a Natural Inhibitor of Hexose and Dehydroascorbic Acid Transport through the Glucose Transporter, GLUT1
J. Biol. Chem., April 12, 1996; 271(15): 8719 - 8724.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K Jewell, C Kapron-Bras, P Jeevaratnam, and S Dedhar
Stimulation of tyrosine phosphorylation of distinct proteins in response to antibody-mediated ligation and clustering of alpha 3 and alpha 6 integrins
J. Cell Sci., January 3, 1995; 108(3): 1165 - 1174.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
R. Ye, A. Bodero, B.-B. Zhou, K. K. Khanna, M. F. Lavin, and S. P. Lees-Miller
The Plant Isoflavenoid Genistein Activates p53 and Chk2 in an ATM-dependent Manner
J. Biol. Chem., February 9, 2001; 276(7): 4828 - 4833.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Strick, P. L. Strissel, S. Borgers, S. L. Smith, and J. D. Rowley
From the Cover: Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia
PNAS, April 25, 2000; 97(9): 4790 - 4795.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.